Haemonetics | HAE - Interest Expense On Debt


Haemonetics reported $5.08M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Cooper Companies USD 20.9M 1.5M Mar/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 83M 4M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
ICU Medical USD 18.53M 2.11M Mar/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Plus Therapeutics USD 62K 25K Dec/2023
Quidel USD 5.63B 5.58B Mar/2026
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 800K 799K Sep/2025
Steris USD 15.8M 700K Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Terumo JPY 1.48B 51M Jun/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
US Physical Therapy USD 3.21M 422K Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026